ABSTRACT Cilnidipine, a 2, 4-dihydropyridine antihypertensive, is poorly bioavailable and
belongs to Biopharmaceutical Classification System Class II. The present study was carried …

Aim: The goal of this research was to formulate and optimize a cost-effective selfemulsifying
drug delivery system (SEDDS) of cilnidipine to increase its dissolution rate. Cilnidipine is a …

Objective The main objective of the current research work was development and
characterization of self-micro emulsifying drug delivery system of cilnidipine which is poorly …

This study aimed to develop a self-micro emulsifying drug delivery system (SMEDDS) for
poorly soluble azelnidipine using Capryol 90 as the oil, Tween 80 as the surfactant, and …

Objective Regardless of having desired therapeutic properties many of the recently
approved drugs are removed from the developmental pipeline for their clinical use due to …

The aim of present research work was to develop self microemulsifying drug delivery system
(SMEDDS) to improve the oral bioavailability of lercanidipine hydrochloride and to evaluate …

Self-microemulsifying drug delivery systems (SMEDDS) of nifedipine were prepared,
characterized and subjected for in-vitro and in-vivo evaluation. Pseudo-ternary phase …

Aims: The aim of this study was to formulate a self-microemulsifying drug delivery system
(SMEDDS) of Lercanidipine HCl (LCH) using medium chain (MC) and short chain (SC) …

The current research is aimed at developing liquid self-nanoemulsifying drug delivery
system (liquid-SNEDDS) of Manidipine for enhanced solubility and oral bioavailability. The …

The present research indicated that a new self-microemulsifying drug delivery systems
(SMEDDS) were used to reduce the food effect of poorly water-soluble drug cinacalcet and …